We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image
  • Published In : Jun 2023
  • Code : CMI3374
  • Pages :120
  • Formats :
      Excel and PDF
  • Industry : Packaging

The global temperature-controlled packaging solutions for pharmaceuticals market was valued at US$ 4.6 Bn in 2022, exhibiting a CAGR of 10.5% in terms of revenue, over the forecast period (2023 to 2030) to reach US$ 10.2 Bn by 2030. Temperature-controlled packaging solutions for pharmaceuticals are an important tool in reducing the risk and maintaining quality of product throughout the supply chain process by stabilizing internal temperature. This system helps to safeguard shipments across every aspect of the medical supply chain. Some of the major application of temperature-controlled packaging solutions are inactive pharmaceutical ingredients with balanced temperature, vaccines, biological samples& products, clinical trials, and medical products with specific timeline requirements.

Global Temperature-controlled Packaging Solutions for Pharmaceuticals Market- Impact of Coronavirus (Covid-19) Pandemic

The COVID-19 pandemic has had a significant impact on the global Temperature-controlled Packaging Solutions for Pharmaceuticals Market. One of the major impacts has been the increase in demand for temperature-controlled packaging solutions due to the need for COVID-19 vaccines and medicines to be transported and stored at specific temperatures. This has resulted in a surge in demand for cold chain logistics, including refrigerated trucks and temperature-controlled containers, as well as specialized packaging solutions to maintain the required temperature range during transit. Another impact of the pandemic has been the disruption to global supply chains, which has affected the availability of raw materials and components used in temperature-controlled packaging solutions. This has led to increase prices for certain materials and longer lead times for production and delivery, which has further impacted the market. Overall, while the COVID-19 pandemic has presented challenges to the global temperature-controlled packaging solutions for pharmaceuticals market, it has also led to increased demand and opportunities for growth and innovation in the industry.

Figure 1. Global Temperature-controlled Packaging Solutions for Pharmaceuticals Market, 2022

TEMPERATURE-CONTROLLED PACKAGING SOLUTIONS FOR PHARMACEUTICALS MARKET

To learn more about this report, request a free sample copy

Global Temperature-controlled Packaging Solutions for Pharmaceuticals Market - Drivers

  • Implementation of strict government rules and regulation by the government

Implementation of strict government rules and regulation by the government in order to improve the distribution practices of pharmaceutical goods are expected to fuel the market growth by forecast period. For example, the Food & Drug Administration (U.S.), Regulation 21 CFR 211.150 ‘Distribution procedures,’ says that pharmaceutical products must be shipped within appropriate temperatures and under accurate conditions in accordance with requirements and appropriate manual, electromechanical, or electronic temperature and humidity recording equipment, devices, and/or logs shall be utilized to document proper storage of prescription drugs. Moreover, growing research and development programs around the globe for enhancing manufacturing and packaging process in pharmaceuticals and biotech industries are expected to propel the market growth of temperature-controlled packaging solutions for pharmaceuticals. Moreover, the increasing development of novel drugs and therapies such as stem cells, r-proteins and monoclonal antibodies alongside pharmaceutical materials have further raised the demand for cold chain packaging system at various stages of product development, thereby propelling market growth.

  • Rising demand due to maintain hygiene and for thermal obligation

The Food and Drug Administration in the U.S. has determined the thermal requirements for storing, handling, and transporting the medications. These containers meet heating requirements as well as the hygiene requirements of healthcare supplies such as organs, vaccinations, medications, and blood. International health organisations such as the World Health Organisation (WHO) have been emphasising the elimination of vaccination waste in recent years. Increasing measures to check vaccine waste are also projected to drive market demand for temperature-controlled pharmaceutical packaging solutions.

Temperature-controlled Packaging Solutions for Pharmaceuticals Market Report Coverage

Report Coverage Details
Base Year: 2022 Market Size in 2022: US$  4.6 Bn
Historical Data for: 2017 to 2021 Forecast Period: 2023 to 2030
Forecast Period 2023 to 2030 CAGR: 10.5% 2030 Value Projection: US$ 10.2 Bn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East & Africa: GCC Countries, Israel, and Rest of Middle East &  South Africa, North Africa, and Central Africa
Segments covered:
  • By Product Type: (Insulated Shippers (Panels and Envelopes, EPS Foam Container, Fiberboard Polyurethane (PUR)), Insulated Protective Shippers Insulated Containers (Chest Style, Upright Style), Others (refrigerants, gel, icepacks, and phase change materials))
  • By Application: (Frozen, Chilled, Ambient)
Companies covered:

Sonoco Products Company, Pelican Biothermal, Sofrigam SA Ltd., Cryopak, Cold Chain Technologies, Envirotainer Ltd., VA-Q-Tec AG, Inmark Packaging, American Aerogel Corporation

Growth Drivers:
  • Implementation of strict government rules and regulation by the government
  • Rising demand due to maintain hygiene and for thermal obligation
Restraints & Challenges:
  • Lack of awareness regarding the benefits of temperature-controlled packaging solutions for pharmaceuticals

Global Temperature-controlled Packaging Solutions for Pharmaceuticals Market - Restraints

  • Lack of awareness regarding the benefits of temperature-controlled packaging solutions for pharmaceuticals

Lack of awareness regarding the benefits of temperature-controlled packaging solutions for pharmaceuticals as only a few companies in the industry utilizes Temperature-controlled packaging solutions for pharmaceuticals is projected to hamper the market growth over the forecast period. Moreover, lots of precautions are need to maintain during packaging of pharmaceutical product such as the container should be clean and dry and so on. Aforementioned factors are projected to restrict the market growth of temperature-controlled packaging solutions for pharmaceuticals.

On the basis of application, in 2021, chilled segment accounted the largest market share of 43.30% in terms of revenue, followed by frozen and ambient, respectively. The demand for chilled temperature-controlled packaging solutions has been increasing due to the rise in global demand for biologics and vaccines, as well as the growing need for temperature-sensitive drugs.

The demand for frozen temperature-controlled packaging solutions is increasing due to the growing need for safe transportation and storage of temperature-sensitive products, particularly in the pharmaceutical and bio-tech industries. The use of frozen packaging solutions helps to prevent spoilage and maintain the efficiency of these products during transportation and storage.

Global Temperature-controlled Packaging Solutions for Pharmaceuticals Market - Market Opportunities

  • Adoption of new high performance convection systems that are efficient for warehousing and supply of pharmaceutical products is expected to offer new growth opportunity to the market of temperature-controlled packaging solutions in pharmaceutical industry. Rising usage of vacuum panel insulation with phase change materials can enhance the shelf life of stored pharmaceutical product. Therefore, the rising adoption of such advanced technologies in the pharmaceutical industry is expected to foster the market growth.
  • Growing focus of pharmaceutical manufacturer to produce drugs and therapies for rare diseases. These drugs are composed of high-value ingredients and have short shelf lives as a result of which they require strict temperature-controlled environment. Thereby, this is expected to foster the Ultra-low Temperature Range packaging solutions.

Figure 2. Global Temperature-controlled Packaging Solutions for Pharmaceuticals Market, 2022

TEMPERATURE-CONTROLLED PACKAGING SOLUTIONS FOR PHARMACEUTICALS MARKET

To learn more about this report, request a free sample copy

Global Temperature-controlled Packaging Solutions for Pharmaceuticals Market - Market Trends

  • The growing need for better product handling of pharmaceutical products that are temperature sensitive has raised the adoption of more advanced temperature-controlled packaging insulation products such as PCMs, VIP, and sheep wool VIP based insulation and PCM-based refrigerants that serve various advantages over conventional polystyrene (EPS) and polyurethane insulated shippers. PCMs and VIPs are comparatively lightweight, offer a wide range of temperature and cut down the distribution costs which is expected to propel the market growth throughout the forecast period (2023-2030).
  • Growing focus of manufacturer to use reusable packaging containers is projected to propel the market growth of temperature-controlled packaging solutions for pharmaceuticals. Due to regulatory pressure and need to reduce the transportation costs, vendors are focusing on adopting reusable packaging container rather than one-way (disposable) systems as it reduces the usage of refrigerants and insulation products that are associated with ozone depletion and global warming. Aforementioned factors are projected to foster the market growth by forecast period.

Global Temperature-controlled Packaging Solutions for Pharmaceuticals Market - Regional Insights

By region, North America dominated the global temperature-controlled packaging solutions for pharmaceuticals market in 2022, reporting 31.10% market share in terms of revenue, followed by Europe and Asia Pacific, respectively. Because of the huge number of pharmaceutical producers and the high utilisation of temperature-controlled pharmaceutical goods in the U.S. and Canada, the North American temperature-controlled packaging solutions for pharmaceuticals market is expected to grow rapidly by (2023-2030).

Temperature-controlled packaging solutions for pharmaceuticals market in Asia Pacific is also predicted to grow more rapidly during the forecast period due to a significant rise in chronic illness incidence and a rising number of clinical trials in countries such as China and India. Because of its growing population and increasing number of disease outbreaks, Asia Pacific has seen technological improvements.

Global Temperature-controlled Packaging Solutions for Pharmaceuticals Market - Recent Developments

  • In March 2021, by establishing new regional offices in the Netherlands, Cold Chain Technologies intended to increase the market for its temperature-controlled systems in the EMEA (Europe, the Middle East, and Africa) region. The cold chain is a set of rules and procedures that ensure the proper storage and distribution of vaccines to health services from the national to the local level. The cold chain is interconnected with refrigeration equipment that allows vaccines to be stored at recommended temperatures to maintain their potency.
  • In November 2020, EOS line of parcel shippers was introduced by Sonoco Products Company. The product's temperature control packaging system is recyclable. Sonoco Products Company manufactures industrial and consumer packaging solutions for customers around the world. The Company's products include flexible packaging, high density film products, and folding cartons.
  • In November 2020, for the purpose of distributing COVID-19 vaccinations, Cold Chain Technologies plans to construct a new plant in Lebanon, United States. Cold Chain Technologies, Inc. specializes in thermal packaging solutions. The Company provide thermal packaging solutions for temperature-sensitive products. Cold Chain Technologies operates globally and is headquartered in Holliston, Massachusetts, United States
  • In February 2020, Pelican BioThermal LLC declared its acquisition with NanoCool LLC. This company is probable to be involved in the manufacture of temperature-controlled packaging systems. Pelican BioThermal is the first cold chain packaging solutions provider to make available a broad and comprehensive portfolio of patented and award-winning single-use and reusable thermal protection packaging solutions for the safe transport of pharmaceuticals, clinical trials, diagnostics, tissue, vaccines and blood.

Global Temperature-controlled Packaging Solutions for Pharmaceuticals Market - Key Players

Key players active in the global temperature-controlled packaging solutions for pharmaceuticals market: Sonoco Products Company, Pelican Biothermal, Sofrigam SA Ltd., Cryopak, Cold Chain Technologies, Envirotainer Ltd., VA-Q-Tec AG, Inmark Packaging, American Aerogel Corporation

Definition: Temperature-controlled pharmaceuticals packaging is commonly used for packing and shipping of various chemical goods that are temperature sensitive, as well as pharmaceutical medications to preserve temperature stability.

Frequently Asked Questions

The global temperature-controlled packaging solutions for pharmaceuticals market is estimated to reach US$ 10.2 billion by the end of 2030, in terms of revenue.

Major players operating in the market include Sonoco Products Company, Pelican Biothermal, Sofrigam SA Ltd., Cryopak, Cold Chain Technologies, Envirotainer Ltd., VA-Q-Tec AG, Inmark Packaging, and American Aerogel Corporation.

Lack of awareness regarding the benefits of temperature-controlled packaging solutions for pharmaceuticals is one of the major factors that is expected to hamper growth of the market over the forecast period.

Implementation of stringent government rules and regulation by the government, in order to improve the distribution practices of pharmaceutical goods is one of the major factors that is expected to propel growth of the market over the forecast period.

The market is estimated to exhibit a CAGR of 10.5% over the forecast period (2023-2030).

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request Discount
Logo

Reliability and Reputation

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Reliability and Reputation

27001:2022

Reliability and Reputation

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo